ISLAA Highlights 2014
Highlights
Embryology, Anatomy & Histopathology of the Left Atrial Appendage
Samuel Asirvatham
Impact of LAA Exclusion on Cardiovascular Physiology and Systemic Homeostasis
Dhanunjaya Lakkireddy
Understanding the Role of LAA in Systemic Thromboembolization
Madhu Reddy
The Role of LAA in Atrial Arrhythmias Origin and Maintenance
Andrea Natale
Risk Assessment Tools for Stroke Prophylaxis and Bleeding – Practical Use
Loren Berenbom
Managing Antiplatelet Therapy and Anticoagulants in Patients with CAD and Atrial Fibrillation
Peter Tadros
Everyone with CHADS2 Score of 2 or More Should Be Considered for LAA Closure/Ligation
Saibal Kar
Moussa Mansour
Essentials of Transseptal Puncture as is Relevant to LAA Closure or Ligation
Réda Ibrahim
Dry Pericardial Access: Rules of Engagement
Randall Lee
Patient Selection: Who is a Good Candidate for LAA Exclusion
Rodney Horton
Understanding Thoracic Anatomy for Minimally Invasive LAA Surgical Ligation: A Surgeon’s Percpective
Steven Hoff
Evolution of Percutaneous Techniques in LAA Occlusion or Exclusion
David R. Holmes Jr.
Past, Present, and Future of Surgical Left Atrial Appendage Exclusion
James Edgerton
Is LAA Occlusion/Exclusion Good Enough to Allow for Discontinuation of Coumadin in Patients with AF and Higher Risk for Thromboembolization?
Douglas Gibson
Zoltan Turi
How to Set Up a LAA Exclusion Program
Vijay Swarup
Transesophageal Echo in LAA Exclusion
Swaminatha Gurudevan
The Role of CT Imaging in Left Atrial Appendage Exclusion
Douglas Gibson
Tips and Tricks to Prevent Complications During LAA Exclusion
Rodney Horton
Managing Complications in LAA Exclusion Procedures
David R. Holmes Jr.
Post Procedural LAA Exclusion Leak – Mechanisms, Implications and Treatment
Andrea Natale
Post Procedural Anticoagulation Management after LAA Exclusion – Understanding an Imperfect Science
Matthew Earnest
Should LAA be Ligated Routinely during an Open Heart Surgery?
Richard Whitlock
James Edgerton
Impact of Surgical Ablation or Exclusion of LAA – Implications to Rhythm Control
Marc Gillinov
LAA Ligation as an Adjunctive Therapy for AF Ablation – The LAALA AF Study
Dhanunjaya Lakkireddy
Who Should Perform LAA Occlusion/Exclusion Procedures? Surgron/EP/Interventional
Dhanunjaya Lakkireddy
Saibal Kar
Watchman Trials
David R. Holmes Jr.
Lariat Trials
Abdi Rasekh
Amplatzer Cardiac Plug Trials
Réda Ibrahim
AtriClip & Other Surgical Tool Trials
James Edgerton
Early Experience with Wavecrest Technology
Andrea Natale
Why Should the LAA Exclusion be a Program and not a Procedure?
Matthew Earnest
Cost Effectiveness of LAA Exclusion
Miguel Valderbanno
LAA Ligation and Occlusion Technology in the Incubator
Samuel Asirvatham
Evolution of Anticoagulation for Stroke Prophylaxis in Patients with Atrial Fibrillation
Daniel Singer
Novel Anticoagulant Trial Review: RELY, Rocket, Aristotle & Engage AF
Michael Ezekowitz
New Generation Anti-coagulation Agents are a Better Choice than Warfarin in the Management of AF
Sanjeev Saksena
John Camm
Peri-Procedural Management of Oral Anticoagulants
Luigi DiBiase
Understanding the Antidotes for Oral and Systemic Anticoagulants
Gerald Nacarelli
Stroke Prophylaxis on a Global Scale – Why Oral Anticoagulants are Still the Best Answer
John Camm
Systemic Anticoagulation – How do you Select Which Drug for Whom?
Jonathon Piccini
Optimization of Stroke Prophylaxis Strategies in Non-Valvular AF – Drugs, Devices or Both?
Samuel Asirvatham
Management of Non-Valvular AF and Stroke – Hurdles I Access to Appropriate Care
Michael Ezekowitz
